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1. Introduction
Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus
Leishmania, which is a public health problem in tropical and subtropical regions of the World.
The parasite is transmitted to mammals by the bite of naturally infected species of female sand
fly vectors (Diptera, Psychodidae: Phlebotominae). The geographic distribution of leishma‐
niasis is limited by distribution of the sand fly vectors. Vectors of the genus Lutzomyia are
responsible for transmitting the disease in the New World and the genus Phlebotomus in the
Old World [1].
Leishmaniases comprise a complex of diseases caused by at least 22 species of Leishmania which
are obligatory intracellular parasites surviving within phagolysosomes of the mononuclear
phagocytes of mammal host. These parasites produce a wide spectrum of diseases, depending
both on the species that initiating infection and on the immunological status of the host, among
other factors. The disease ranges from: simple cutaneous lesion developing at the site of the
sand fly bite, with skin ulcers that usually appears on exposed part of the body, such as the
face, arms and legs, that could be heal within a few months, leaving scars; mucocutaneous
form with lesions that can partially or totally destroy the mucous membranes of the nose,
mouth and throat cavities and surrounding tissues and producing extensive disfiguring, being
difficult to treat; diffuse cutaneous that is rare, but more serious complication which occurs
when the immune system fails to react effectively to infection with multiple non ulcerative
nodules and visceral leishmaniasis, also known as kala azar, that is characterized by high fever,
substantial weight loss, swelling of the spleen and liver, and anemia. If left untreated, the
visceral leishmaniasis can have a fatality rate as high as 100% within two years. The disease
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presents high morbidity in tegumentary leishmaniasis and high mortality levels in visceral
leishmaniasis [2].
Reported from 98 countries, in six continents, the leishmaniases are responsible for the second-
highest number of deaths due to parasitic infection globally and are still one of the world’s
most neglected diseases, affecting largely the poorest of the poor, mainly in developing
countries. It is associated with malnutrition, displacement, poor housing, illiteracy, gender
discrimination, weakness of the immune system and lack of resources. Approximately 0.2 to
0.4 and 0.7 to 1.2 million of visceral leishmaniasis and tegumentary leishmaniasis cases
respectively, occur each year, with 350 million people in worldwide living at risk to be infected,
based on World Health Organization data. Leishmaniasis is the third most important vector-
borne disease, and the estimated disease burden places it second in mortality and fourth in
morbidity among tropical infections [3].
More than 90% cases of visceral leishmaniasis occur in six countries: India, Bangladesh, Sudan,
South Sudan, Ethiopia and Brazil [3]. Certainly, these data are underestimated, since not all
affected nations have a system of compulsory notification of cases, and even those countries
where the leishmaniasis is a reportable disease there are logistical problems that increase the
imprecision of the estimations [4].
The distribution of tegumentary leishmaniasis is more extensive, occurring in three epide‐
miological regions, the Americas, the Mediterranean basin and Western Asia from the Middle
East to Central Asia. Ten countries have 70-75% of cases worldwide: Afghanistan, Algeria,
Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru. Mortality data were
extremely sparse and generally represent hospital-based deaths only [3].
Several studies have reported the expansion of leishmaniasis worldwide and occurrence of
cases in endemic regions have been recurrent and the global number of cases has increased in
recent decades. The main reasons given for such increases are related to environmental
changes, agricultural development, migration of non-immune people to endemic areas, and,
in part, by improved diagnosis, but are also due to other factors such as inadequate reservoir
or vector control. More recently, an increased detection of disease associated with opportun‐
istic HIV infections and visceral leishmaniasis, especially in intravenous drug users in South-
western Europe and other endemic areas was verified. A recent report by the World Health
Organization [4] indicated that people with AIDS have become the largest risk group for
human visceral leishmaniasis in Southern Europe, and that their co-infection is expected to
present an increasing problem in areas were HIV and human visceral leishmaniasis overlap,
especially in Brazil, Africa, and India. In areas endemic for visceral leishmaniasis, many people
have asymptomatic infection. A concomitant HIV infection increases the risk of developing
active visceral leishmaniasis by between 100 and 2320 times [5]. In Southern Europe, up to 70%
of cases of visceral leishmaniasis in adults are associated with HIV infection. Sum up this the
urbanization, deforestation, the emergence of antileishmanial drug resistance, economic
development itself is also increasing exposure, tourism, wars and in some areas military
training in forest or desert [6].
Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment196
A large number of different Leishmania species cause tegumentary disease belonging to both
subgenera Leishmania and Viannia (which are present only in the America). Epidemiological
studies have revealed that except Leishmania tropica, all of other species that cause tegumentary
leishmaniasis are zoonoses that initially affect animals (rodents, sylvatic edentates, marsupials
and non-human primates) and eventually humans [7].
Visceral leishmaniasis or kala azar, is almost always fatal if not treated. In the Americas as well
in Mediterranean Basin, Middle East, West Africa and Central Asia, visceral leishmaniasis is
caused by Leishmania infantum (=L. chagasi) and is a zoonosis with an animal reservoir and
occasional human infections. However, visceral leishmaniasis in India and Africa caused by
Leishmania donovani has an anthroponotic cycle with inter-human transmission. Despite the
ecological differences, the disease is very similar in their clinical manifestations. It is charac‐
terized by targeting visceral organs and results in the development of syndromes comprised
of irregular fever, substantial weight loss, splenomegaly, hepatomegaly, hypergammaglobu‐
linemia, pancytopenia, anemia and hypoalbuminaemia witch is associated with edema and
other features such as malnutrition [8].
Patients treated and cured for visceral leishmaniasis caused by L. donovani may subsequent
develop Post-kala azar dermal leishmaniasis (PKDL). Post-kala azar dermal leishmaniasis is
an unusual dermatosis that develops as a sequel in 5–15% of cured cases of kala azar after
months or years of treatment in India [9].
L. infantum maintains a zoonotic cycle mostly involved canine host, and canine visceral
leishmaniasis is also a veterinary problem. The recommended control methods for the disease
have only been partially effective. The continued endemicity of zoonotic visceral leishmaniasis,
its recent appearance in urban areas of Latin America [10] and its increasing importance as an
opportunistic infection among persons infected with human immunodeficiency virus, indicate
that present control methods for the disease are ineffective and that new control strategies are
needed. Prevention of the disease in dogs appears to be the best approach for interrupting the
domestic cycle of zoonotic visceral leishmaniasis. Not all L. infantum infections lead to overt
clinical disease. In Brazil were described ratios of 8-18 incident asymptomatic infections to 1
incident clinical case [11].
Zoonotic visceral leishmaniasis is an important emerging parasitic disease of humans and
dogs. The most feasible approach would seem to be a canine vaccine that protects dogs from
developing disease and from becoming peridomestic reservoirs of the parasite. There are two
vaccines developed in Brazil, but not used for routine immunization against zoonotic visceral
leishmaniasis. There is clear evidence that in the zoonotic visceral leishmaniasis the parasites
are maintained through the bite of infected female phlebotomine sand flies, and the prevalence
of disease has been expanding throughout the world [12].
Many studies suggest that L. infantum in urban and peri-urban settings is a phenomenon
reported in several countries when zoonotic visceral leishmaniasis is endemic. Dogs are the
only confirmed primary reservoir of infection. Meta-analysis studies confirm that infectious‐
ness is higher in symptomatic infection; infectiousness is also higher in European than South
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American studies [13]. A high prevalence of infection has been reported from an increasing
number of domestic and wild mammals; updated host ranges are provided.
The domestic dog is the most important domestic reservoir in urban and rural areas [14]. The
dogs have intense cutaneous parasitism, favoring infection of vectors and play an important
role in the epidemiological chain of human visceral leishmaniasis. Therefore, although visceral
leishmaniasis remains more prevalent among dogs than humans, the presence of infected dogs
may increase the risk for human infection in some situation [15]. There is a close canine
relationship with human in both rural and urban areas, and canine cases usually precede
human cases.
The strategies of the control of leishmaniasis have varied very little for decades, but in recent
years there have been exciting advances in diagnosis, treatment and prevention. These include
an immunochromatographic dipstick for diagnosing visceral leishmaniasis; the licensing of
miltefosine, the first oral drug for visceral leishmaniasis; and evidence that the incidence of
zoonotic visceral leishmaniasis in children can be reduced by providing dogs with deltameth‐
rin collars. In the context of zoonotic visceral leishmaniasis measures of control transmission
vary according to local epidemiology [10].
The canine visceral leishmaniasis is clinically alike to human infection, but with dermal lesions
normally found in infected-symptomatic dogs. The infection in dogs carries a wide-ranging
clinical signs related to high antileishmanial antibody levels and lack of a cell-mediated
response. Leishmania are intracellular parasites and, under immunodeficiency conditions, they
multiply and migrate from lymphoid tissue to other organs, displaying severe clinical and
pathological changes which could leads to animal death. Although, infections in endemic areas
are high, not all dogs infected develop the disease, in some dogs several clinical signs of disease
appear in short time after infection. Part of dog remains infected for a long time, but without
clinical signs of disease. There are evidences that the host’s genetics could play a major role in
susceptibility or resistance [16]. Canine visceral leishmaniasis has a high prevalence of
infection, involving as much as 63-80% of the population [17, 18] and is accompanied by a
lower rate of apparent clinical disease.
Dogs have also been found to be infected with other Leishmania spp., and their role in these
infections is probably more than incidental. In the wide geographical range of L. infantum, there
are many contrasting situations, depending on whether the dogs are domestic, stray or feral
and on the animals’ place in society. Naturally infected asymptomatic dogs have been
demonstrated to be easily infective to sand flies under experimental conditions (xenodiagno‐
sis). Therefore, the role they may play in the cycle should not be underestimated, as more than
50% of all infected dogs are asymptomatic carriers. This is due to the high degree of parasitism
on the skin of the infected animal and greater susceptibility to disease in many of them [19].
Thus, occurrence of infection in endemic regions of sand flies is facilitated, and the dog plays
a decisive role in keeping the disease cycle transmission under favorable conditions, with high
population density vector and dogs, the infection spreads rapidly and extensively in the
population of vectors and also in the canine population [20, 21].
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In the Mediterranean basin, human cases and canine cases are treated with antileishmanial
drugs. In this area the use of individual measures to protect dogs from sand fly bites using
insecticides are common practices, but no public health surveillance and control interventions
such as applied, for example, in Brazil are in place [22]. Despite years of effort using control
measures the number of infected dogs in South-western Europe alone are approximately at
2.5 million [23] and the number of infected dogs in South America also is estimated in millions.
In Latin America the strategies of control of visceral leishmaniasis are based in the diagnosis
of human and canine visceral leishmaniasis, treatment of human cases, control of infected dogs
using immunological test to diagnose L. infantum infections and to cull putative infected
animals and also vector control by spraying insecticides with residual action. Animal reservoir
control through environmental management is expensive and difficult to implement; the
efficacy of dog culling is questionable [24].
In the context of visceral leishmaniasis prophylaxis, the rapid and accurate diagnosis of
infected dogs is critical for the control. The correct diagnosis is essential for detection of L.
infantum infection in both symptomatic and asymptomatic dogs. Reliable clinical signs of
canine visceral leishmaniasis are not obvious until late in the disease. The precise diagnosis of
canine visceral leishmaniasis is complex and must be performed combined to parasitological,
immunological and molecular tests [25]. Although, the disease burden persists due to techni‐
cal, managerial, financial and political constraints [24].
Current diagnosis methods of zoonotic visceral leishmaniasis are based on parasite demon‐
stration in tissue stained smears. Leishmania amastigotes can be demonstrated in impression
smears made from fine needle aspirates of lymph nodes, spleen or bone marrow, and stained
with Giemsa or a quick stain such as Rapid Panotic (Laborclin®). In dogs impression smears
can also be made from dermal lesions, such as those found on the tip of the ear, after scraping
of the skin. The material is used for culture, cytology or examination of the parasites presence.
Although demonstration of even a single amastigote upon microscopic examination of tissue
smears is considered sufficient for positive diagnosis of disease, the sensitivity of the tissue
examination varies, being splenic aspirate more sensitivity, than bone marrow or the lymph
node aspiration. The specificity is high, but the sensitivity, except in the case of spleen aspirate,
is low. However, spleen aspiration can be complicated by life threatening hemorrhages in
~0.1% of the cases. The identification of amastigotes requires considered expertise and training
and is subject to the ability of the observer [26]. Diagnosis may also be established by the
inoculation of hamsters with infected tissues and monitoring their clinical signs. This technique
is used mostly in research parasite identification, requires considerable expertise and training
and in our own experience is can be laborious and time consuming.
Other several methods are described to diagnosis human and canine visceral leishmaniasis
and the most employed are immunodiagnostic tests for antibody detection. Serodiagnosis is
particularly useful in zoonotic visceral leishmaniasis, since humans and dogs present hyper‐
gammaglobulinemia. Dogs with canine visceral leishmaniasis infection, either symptomatic
or asymptomatic, will almost always demonstrate a specific humoral response. The serological
test used crude antigen preparations and they are limited in both specificity and assay
reproducibility, and there are cross-reactions with other Leishmania species and with Trypano‐
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soma cruzi. Weak responses in some dogs and presence of antibodies in some healthy individ‐
uals are inherent limitations with antibody based diagnostics according our own observations.
The use of crude Leishmania antigens is thought to underestimate the prevalence of canine
visceral leishmaniasis [27, 28].
In Latin America, mainly in Brazil, the serological test is extensive used as part of control
campaigns to remove seropositive animals for euthanasia often not with the agreement of the
owners. The Brazilian Ministry of Health, through the Control Program of Visceral Leishmania‐
sis, has instituted specific measures to control of the disease using immunofluorescent anti‐
body test (IFAT) and enzyme-linked immunosorbent assay (ELISA). To date, however, the
actions of this program have had little impact. Control strategy based on the euthanasia of
seropositive dogs depended on mass serological surveys usually with blood samples collect‐
ed generally on filter paper. According reliable diagnostic test is essential for detection of L.
infantum  infection. This complex panorama certainly generates significant changes in the
measures of accuracy of the serological tests and this negative outcome has been ascribed to
delays in detecting and eliminating infected dogs, the tendency to replace infected dogs by
susceptible puppies, the low sensitivity of the available serological methods, the high inci‐
dence of infected dogs and the presence of cross reactions in the used IFAT and ELISA meth‐
ods [29, 30]. Thus, to remove seropositive dogs is insufficient as a measure for eradicating visceral
leishmaniasis in dogs. However, the force of transmission of infection among dogs can be reduced
by such programs. The results of this intervention study suggest that the elimination of the
majority of seropositive dogs may affect the cumulative incidence of seroconversion in dogs
temporarily and may also diminish the incidence of human cases of visceral leishmaniasis [31].
IFAT has low specificity, demand highly trained personnel, it is time consuming and expen‐
sive, thus is not adaptable to large-scale epidemiological studies (although it is used in Latin
America) and the requirement of sophisticated laboratory conditions prohibit its application
in the field. ELISA is the most commonly used test for immunodiagnosis of canine visceral
leishmaniasis. The antigen used are traditionally derived from promastigotes cultivated in
vitro and consist of a repertoire of a least 30 somatic antigens and several surface components.
It results that most immunodiagnostic methods have been hampered by problems of cross-
reactivity of species within the trypanosomatids as well microorganisms phylogenetically
distant [32]. According WHO (2010) [5] serology existing tools (IFAT and ELISA) are difficult
to decentralize, direct agglutination test (DAT) can be used at the periphery but needs cold
chain and shaking during transportation frequently hampers the antigen. Parasitological
existing tools (spleen, bone marrow and lymph node aspirates) are either invasive methods
and difficult to decentralize (spleen and bone marrow) or of low sensitivity (lymph nodes).
The recombinant antigens rK9, rK26, rK39 used in the ELISA test seemed to be most suited for
point-of-care diagnosis of symptomatic cases of dogs but lack sensitivity for asymptomatic
ones [32, 29].The K39 test was not able to detect active infection in dogs with low IFAT titers,
in the range of 1:40 to 1:320. Other tests such as DAT, agglutination screen test (FAST), that is
a DAT modified, rapid tests like the immunochromatographic-dipstick TRALD (Test Rapid
Leishmania donovani) and other using the recombinant rK9, rK26 and rK39 proteins of L.
infantum are used in the routine diagnosis in several countries but not in Latin America [33].
The direct agglutination test, in which stained parasites are agglutinated by serum antibodies,
is popular in Iran and Africa, but variation between batches and the high cost of commercially
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available antigen are limiting factors. The most recent platform for serodiagnosis by immu‐
nochromatography technology is the Dual Path Platform (DPP®), which may in the near future
replace other immunochromatographic tests [31]. In Brazil, the Dual Path Platform test began
to be incorporated to epidemiological routines [34].
Due to the problems presented by serological tests, different molecular methods have been
evaluated for leishmaniasis diagnosis and Polymerase Chain Reaction (PCR) is presently the
principal method for molecular diagnosis of Leishmania. PCR-based methods for detecting
Leishmania species in clinical samples have been developed which amplify rRNA and miniexon
genes, kinetoplast DNA (kDNA) and repeated nuclear DNA sequences. These methods are of
variable specificity; some are generic and can detect all Leishmania species while other methods
identify the infecting Leishmania parasite to the species level. These techniques mostly have a
high sensitivity although some, such as PCR with a subsequent hybridization increase the
sensitivity of the assay [35]. The real-time PCR was recently introduced for detection and
typing of Leishmania [36, 37, 38] with the advantages of speed and reduced risk of sample
contamination, since monitoring of amplification is conducted as the reaction proceeds. Many
studies have reported that real-time PCR has greater sensitivity than conventional PCR for
canine visceral leishmaniasis diagnosis and is reproducible in diagnostic routines [39]. PCR
based assays are being suggested as useful methods to detect subclinical infections and as a
possible addition to serological methods to definitively diagnose inconclusive cases that show
low antibody titers or cross reactivity [26].The molecular diagnostics using PCR has demon‐
strated high sensitivity shown by different studies, than other conventional diagnostic
techniques for diagnosis of the canine visceral leishmaniasis, on other hand, PCR methods can
vary according to the biological sample examined [40]. This technique has several advantages
over other detection methods, especially in the field situation. PCR advantages included, the
ability to use very small amounts of target material, the fast detection of Leishmania in all
material that are used for diagnosis, including skin biopsies, touch preparations, aspirates from
lymph nodes, bone marrow, spleen, buffy coat and blood spots collected on filter paper and
can be used to simultaneous detection and typing of the parasite [26].
PCR based assays can disclose the presence of parasite DNA very early on, even before
seroconversion [21]. The detection of Leishmania DNA based on PCR represents an alternative
for visceral leishmaniasis diagnosis with highly sensitive, specific and versatile methods [10].
PCR are consistently been shown to be better than microscopy or parasite culture, particularly
in samples with low parasite loads [6]. As stated above, several types of canine clinical samples
have been used for diagnosis with these techniques [41, 42, 43, 44]. The skin is the principal
access point for the phlebotomines and hence represents the principal pathway for infection.
Different studies have demonstrated high positive indices for PCR using skin samples of dogs
with different clinical signs, and it has been suggested that these techniques based on use of
ear skin could be the best procedure for diagnosing canine visceral leishmaniasis [44]. The
collection of this sample, however, is painful, bloody and invasive, requiring local anesthesia
and aseptic manipulation. The parasites show natural tropism towards lymphoid tissues and
many studies have shown that these tissues are a good source for Leishmania DNA detection.
PCR performed using bone marrow has shown high sensitivity [45], but the procedure of bone
marrow sampling is very invasive and traumatic. Complete anesthesia of the animal is
necessary, which usually results in opposition by dog owners. Lymph node are one of the
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preferred internal tissues for L. infantum multiplication and lymph node aspirates also allow
high sensitivities by PCR [45, 46], but again the collection procedure is invasive, offering risk
of infection for the animal and demands very well trained personnel. These limitations make
these samples unsuitable for large-scale surveys. Blood is considered a less invasive sample
type. The evaluation of blood for the diagnosis of canine visceral leishmaniasis by PCR is still
contradictory. Some studies provided evidence that this clinical sample showed a good
performance by PCR [42, 47, 48, 49]. In contrast, other authors encountered problems with the
use of blood related to DNA preparation, high frequency of PCR inhibitors in dog blood,
variations of the parasite load in the course of infection and low sensitivity [40, 41, 50].
Besides to provide high sensitivity, the ideal source of biological material for molecular
diagnosis of canine visceral leishmaniasis would be a non-invasive, painless and easily
obtained sample, which could be more accepted by the dog-owners and obtained outside
veterinary centers. The conjunctival swab sample is acquired by a non-invasive procedure that
uses a sterile swab for sampling the dog conjunctiva (Figure 1) and fulfills these criteria.
Figure 1. Conjunctival swab sampling method
2. Conjunctival swab
Previous studies had initially pointed that the conjunctiva of infected dogs was a good source
of Leishmania DNA. Berrahal et al. (1996)[51] investigating asymptomatic carriers was able to
identify 15 of 16 dogs (93.8%) by PCR using 5mg of conjunctiva biopsies. In the same study 9
of 14 asymptomatic dogs (64.3%) were positive for skin samples PCR. All these dogs were
negative for ELISA and IFAT but immunoblotting detected specific antibodies in 66% of the
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animals. Solano-Gallego et al. (2001)[17] identified by PCR 32 out 100 dogs (32%) using
conjunctiva biopsies while in the same group 17 out of 95 animals (17.8%) had positive bone
marrow and 51 out of 100 (51%) presented positive skin. Reithinger et al. (2002)[52] in a study
dealing with tissue tropism and parasite dissemination in two domestic dogs was also able to
detect by PCR and histology Leishmania (Viannia) spp. in conjunctiva biopsies of both animals.
The first work using the conjunctival swab was performed by Strauss-Ayali et al. (2004)[50].
Ninety-eight dogs were examined in this study and divided in four groups. The group A
included 24 seropositive symptomatic animals; in the group B were incorporated 65 seroneg‐
ative dogs; the group C was formed by six male five-month-old beagle dogs that were
experimentally infected with L. infantum; and the group D included nine seronegative beagle
dogs with no clinical signs of leishmaniasis. In the group A, 83% of the conjunctival samples
from either the right or the left conjunctivas were positive by ITS1-PCR and 92% of the dogs
were found positives when results from both eyes were combined. Skin scrapings obtained
from two areas of the back and from skin lesions were positive for 29%, 41% and 46% of the
samples, respectively. Sixty five percent of the dogs were found positive if all skin tests were
combined. ITS1-PCR from buffy coat and blood were positive for 57% and 17% of the dogs in
that order. Spleen and lymph node aspirates were PCR positives for 77% and 67% of the dogs,
respectively. Positives cultures were obtained from 61% and 37% of the spleen and lymph node
samples and 74% of the dogs were positive considering the sum of results of both cultures. All
group B seronegative dogs were found to be negative by ITS1-PCR in both conjunctival
samples and buffy coat. In this study a sensitivity of 92% and a specificity of 100% were found
for detection of L. infantum DNA in naturally symptomatic infected dogs by using conjuntival
swab samples. The experimentally infected dogs (group C) were evaluated every two weeks
for 90 days. Forty five days after infection 5 (83%) of the 6 dogs had at least one conjunctival
sample found to be positive by PCR while the correspondent optical density values for ELISA
were still below the cutoff value. After 60 days of infection the number of positive dogs by
conjunctival PCR remained the same but all dogs have seroconverted. At 75 and 90 days after
infection, at least one conjunctival sample from 100% of the dogs was found to be positive.
Conjunctival, spleen and buffy coat samples were PCR negative for group D control animals
(seronegative beagle dogs) and spleen cultures were also negative for L. infantum. The study
demonstrated that sensitivity obtained by the conjunctival swab PCR was superior to that
obtained by culture or by PCR using invasively obtained samples. The work also showed that
conjunctival PCR was positive in the experimentally infected dogs before the seroconvertion
and was superior to serologic testing for early diagnosis.
A study evaluating the conjunctival swab for canine visceral leishmaniasis diagnosis by the
kDNA PCR-hybridization method in a Brazilian endemic region of leishmaniasis in Belo
Horizonte, Minas Gerais State, was accomplished by Ferreira et al. (2008)[41]. In the kDNA
PCR-hibridization method the PCR amplified products (a 120 bp conserved region of kDNA
minicircles) are hybridized with minicircle cloned probes labeled with 32P radionuclide. The
study also evaluated two procedures of DNA extraction from conjunctival swabs: phenol
chloroform and boiling. The efficiency of the two DNA extraction methods was first evaluated,
in vitro, using cotton swabs seeded with different numbers of L. infantum promastigotes. By
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using the phenol chloroform method of DNA extraction, the kDNA PCR-hybridization
procedure was able to detect down to a single parasite per swab, while the limit of detection
for the boiling method was 25 parasites. Afterward, two groups of 23 seropositive symptomatic
dogs were evaluated. Conjunctival swab samples were obtained from both eyes of each animal.
The DNA extraction was performed by the phenol chloroform method in group 1 and by
boiling in group 2. Blood was also collected from each animal so that 30μL were spotted onto
filter paper and 1.0ml was treated to obtain the buffy coat. The DNA extraction from the buffy
coat and filter paper was accomplished by identical procedures in both groups using com‐
mercial kits. After hybridization step, the positivities calculated for conjunctival swab com‐
bining the results of the right (RC) and left conjunctivas (LC), were 91.3% and 65.2% for groups
1 and 2, respectively. The kDNA PCR-hybridization positivities calculated for the RC and LC
separately were 73.9% (17/23) for RC and 91.3% (21/23) for LC in group 1, 52.2% (12/23) for RC
and 56.5% (13/23) for LC in group 2. The results obtained for buffy coat and filter paper were
21.7% (5/23) and 30.4% (7/23) in the group 1, 34.8% (8/23) and 43.5% (10/23) in group 2,
respectively. All the seronegative control dogs were negative for the kDNA PCR-hybridization
assay in conjunctival swab, filter paper and buffy coat. The highest frequency of positivity was
obtained by the association between conjunctival swab samples and DNA extraction by phenol
chloroform.
Di Muccio et al. (2008)[53] evaluated the conjunctival swab for the early detection of Leishma‐
nia-Dog contacts in a group of Italian dogs. The following samples were also examined:
peripheral blood for IFAT serology, bone marrow and lymph node aspirates for culture, and
bone marrow and peripheral blood buffy coat for molecular analysis. Fifty three sets of samples
were obtained from 38 dogs. The conjuntival swab (from left and right conjunctivas) PCR was
positive for 50 samples (94.3%) while bone marrow plus peripheral blood PCR was positive
for 41 samples (77.4%). The IFAT and cultures (bone marrow and lymph node) were positive
for 66% and 38.9% of the samples in that order. The PCR sensitivity obtained from conjunctival
swab samples proved to be superior to that of systemic samples and much higher than
antibody detection. The study highlights that conjunctival swab positives included some
asymptomatic animals, as well as drug-treated infected dogs converted to negative at the bone
marrow PCR.
The sensitivity of four molecular methods for conjunctival swab samples was compared by
Pilatti et al. (2009)[54] in a group of seropositive symptomatic animals. The following methods
were used: kDNA PCR-hybridization, kDNA seminested PCR (kDNA snPCR), internal
transcribed spacer 1 nested PCR (ITS-1 nPCR) and Leishmania nested PCR (LnPCR). All
methods had two steps: a first amplification followed by hybridization or by a new amplifi‐
cation (nested or semi-nested).Two methods (kDNA PCR-Hybridization and kDNA snPCR)
used primers targeted to the minicircles of kinetoplast DNA (kDNA) and the other two
methods to the coding (LnPCR) and intergenic noncoding regions (ITS-1 nPCR) of ribosomal
rRNA genes. For all methods DNA samples of 1.0μl were used. The kDNA PCR–Hybridization
was positive for 22/23 dogs (95.6%) and for 40/46 samples (86.9%), considering the right and
the left conjunctivas. kDNA snPCR was positive for 21/23 dogs (91.3%) and for 40/46 samples
(86.9%). The ITS 1 nPCR and LnPCR were both able to detect the parasites in 17/23 dogs (73.9%)
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and respectively 29/46 (63%) and 30/46 (65.2%) samples. The positivities of the kDNA based
methods were significantly higher. The authors credited this result to the fact that there are
~10, 000 kDNA minicircles per parasite, while the SSU rRNA and ITS-1 targets have less than
200 copies per cell. In this study the conjunctival swab associated with the most sensitive kDNA
PCR based assays showed sensitivities above of 90% for symptomatic dogs.
The first study investigating the efficacy of conjunctival swab PCR for visceral leishmaniasis
diagnosis in naturally infected asymptomatic dogs was performed by Leite et al. (2010)[40].
Asymptomatic animals may represent a high percentage of infected dogs in areas of ende‐
micity and they serve as reservoir for vector transmission to susceptible animals and humans.
Symptomatic dogs usually produce high levels of specific antibodies which can be easily
detected, but the sensitivity of antibody detection is generally lower in early or in asympto‐
matic canine infections. In this report conjunctival swab sensitivity was compared to two less
invasive samples potentially useful for massive screening of dogs: blood and skin biopsies.
The study was performed with 30 asymptomatic dogs, all presenting serological and parasi‐
tological positive tests. The samples were analyzed by two PCR methods: kDNA PCR-
hybridization and ITS-1 nPCR. Using conjunctival swab samples the kDNA PCR-
hybridization was able to detected parasite DNA in 24/30 dogs (80%) using the right
conjunctiva (RC) and 23/30 dogs (76.6%) with the left conjunctiva (LC). The positivity obtained
combining RC and LC results was of 90% (27/30 dogs). A total of 17/30 dogs (56.7%) were
positive by means of skin biopsies and 4/30 dogs (13.3%) with Blood. The assay of conjunctval
swab samples by ITS-1 nPCR revealed that 25/30 dogs (83.3%) were positive when using RC
and 20/30 dogs (66.6%) were positive when using LC. The conjunctival swab positivity
obtained by ITS-1 nPCR combining RC and LC was of 83.3%. Via the same method 15/30 dogs
(50.0%) were positive by skin biopsies and 17/30 dogs (56.7%) with blood. The kDNA PCR-
hybridization and ITS-1 nPCR methods showed similar sensitivities for conjunctival swab and
skin biopsy samples. On the other hand, for blood samples, the positivity of ITS-1 nPCR was
significantly higher than the one obtained by the kDNA PCR-hybridization, indicating that
sensitivity of PCR methods can vary according to the biological sample examined. This study
demonstrated the conjunctival swab potential to detect Leishmania DNA in asymptomatic dogs
and that the sensitivities obtained with asymptomatic animals were similar to the ones
observed in previous studies for conjunctival swab PCR in symptomatic dogs [41, 50].
A research conducted by Gramiccia et al. (2010)[55], in a public kennel for stray dogs in Santa
Maria Capua Vetere (Campania region, Southern Italy), evaluated the diagnostic performance
of conjunctival swab associated to a nested PCR assay for both the early and the late detection
of Leishmania contacts in dogs exposed to risk of transmission. The nested PCR assay was
performed using primers addressed to the small subunit rRNA gene. Two groups of animals
were used: (A) a cohort of 65 IFAT and conjunctival swab PCR negative dogs exposed to and
followed up during a full sand fly season (July-November 2008), and (B) a cohort of 17 IFAT
and conjunctival swab PCR negative dogs but positive at the peripheral blood buffy-coat PCR
at July 2008. These animals were examined again in September and November 2008, by buffy
coat PCR and in May 2009 along with conjunctival swab PCR. None of group A dogs converted
to positive by conjunctival swab PCR or IFAT during the transmission season. In relation to
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group B dogs, all remained IFAT seronegative till the end of the study, except for one animal.
The results of buffy coat PCR showed an intermittent tendency with transient or full conversion
to negative involving 4 and 11 dogs respectively, till November 2008. Eight two percent of the
dogs (14/17) converted to negative on May 2009 by buffy coat PCR. However, the conjunctival
swab PCR was negative for all dogs at November 2008, but 71% of the animals (12/17)
converted to positive by this technique on May 2009. The positive control group, in which were
included 10 asymptomatic dogs positives at high IFAT titres at the initial screening performed
in 2008, when examined again in May 2009 presented 80% of the dogs positives by conjunctival
swab PCR and 60% positive by buffy coat PCR. The conjunctival PCR was not found effective
for the very early detection of infection, but this investigation demonstrated a slowly conver‐
sion of conjunctival PCR to positive in a high rate of dogs even in absence of seroconversion.
The buffy coat PCR although could represent an early marker of leishmanial infection tends
to be transient and prone to negative conversion. The authors considered the conjunctival swab
PCR as a non-invasive alternative to current serological and molecular methods to asses
Leishmania exposure in dogs.
Leite et al. 2011[56] carried out a comparison between the diagnosis by conjunctival swab PCR
and serology in a group of 42 police dogs vaccinated against visceral leishmaniasis. The dogs
belonged to the Military Police of the State of Minas Gerais (PMMG), Brazil. All dogs were
vaccinated against visceral leishmaniasis with Leishmune® vaccine (Fort Dodge, Brazil)
according to the manufacturer’s protocol. The serologic assays were performed one year after
vaccination independently by three laboratories: Laboratories 1 and 2 were private laboratories
and Laboratory 3 was the National Reference Laboratory of Brazil. ELISA and IFAT were the
serologic tests used. The laboratory 1 analyzed all 42 dogs and found 15 positive animals and
4 were identified as indeterminate. Laboratory 2 confirmed only 3 reactive dogs and 2 were
classified as indeterminate. Laboratory 3 confirmed 7 reactive dogs and found 3 indeterminate
animals. The consolidated serologic result was considered positive when ELISA and IFAT
were simultaneously reagents or ELISA was non reagent and IFAT showed fluorescence at
sera dilution of 1:80. The results were considered indeterminate when ELISA was non reagent
and IFAT showed fluorescence at sera dilution of 1:40 or ELISA was reagent and IFAT was
non reagent. Although the three laboratories used the same official diagnostic kits to perform
the serologic assays, a significant difference in the results were verified among them. For this
reason only the seven cases confirmed by Lab 3 (the National Reference Laboratory) were
considered for euthanasia. The autopsy of the euthanized animals showed organ and tissue
morphologic changes related to visceral leishmaniasis, except for one dog. The molecular
diagnosis by PCR using the conjunctival swab procedure was performed in all 42 animals and
was able to detect Leishmania DNA in 17 dogs. Comparing the PCR results with those obtained
by serologic assay of Laboratory 1, PCR was positive for 10 reactive and one indeterminate
case, but was negative for 5 reactive and 3 indeterminate cases. Conjunctival swab PCR was
also positive for 5 non-reactive dogs, all of them asymptomatic. The reactive cases according
to Laboratory 1 that were PCR-negative tested negative in the serologic assays of Laboratories
2 and 3, and may represent false positives. The same occurred with the three indeterminate
cases from Laboratory 1 that were PCR negatives. For the Laboratories 2 and 3 the PCR was
positive for all reactive and indeterminate cases. The PCR assay also confirmed all cases
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simultaneously reactive in the serologic tests of two laboratories. The study suggested the use
of molecular methods as complementary tools for an accurate diagnosis of canine visceral
leishmaniasis and pointed that the conjunctival swab procedure could be especially useful as
a confirmatory diagnosis for asymptomatic vaccinated dogs that test positive in the serologic
assay, since a fraction of these animals might test positive due the vaccination.
A real-time PCR method based on TaqMan which amplifies a 122 bp fragment of the highly
conserved kDNA minicircles of L. infantum was developed and standardized by Galleti et al.
(2011)[57]. In order to evaluate the method, clinical samples of bone marrow, lymph node
aspirates, blood and conjunctival swab were collected from 88 dogs for a total of 177 samples.
Additional samples of spleen, kidney, lung and liver were also obtained from dead dogs.
Twenty seven samples derived from 15 dogs tested positive in the assay. Three of these positive
samples corresponded to conjunctival swabs, for which were found a mean number of
parasites for PCR reaction of 29.4, 0.35 and 170. The author’s opinion was that the conjunctival
swab might be suitable for diagnosis of Leishmania infection only in case of high parasitic load,
but improvements in the sampling and DNA extraction procedures could enhance the
sensitivity obtained.
The diagnostic utility of conjunctival swab to detect Leishmania infection in a canine population
of highly endemic area of leishmaniasis was investigated by Lombardo et al. (2012)[58]. One
hundred sixty-three dogs, randomly recruited in various provinces of Sicily, were enrolled.
The real-time PCR based on TaqMan (Applied Biosystems) using primers targeting the
constant region of the minicircle Kinetoplast DNA, was the molecular assay used. Samples of
blood, lymph node, conjunctival and oral swabs were obtained for the molecular assay. From
138 dogs the conjunctival swabs were collected from one eye (Group A) whereas from an
additional 25 animals (Group B) both eyes were sampled. Indirect fluorescent antibody test
(IFAT), delayed-type hypersensitivity reaction to leishmanin (DTH) and physical examination
were also performed. The positivity found for serology and DTH were 27.0% and 73.8%, in
that order. The positive PCR percentages for lymph node, conjunctival swab, oral swab and
blood were: 24.5%, 22.1%, 8.7% and 5.5%, respectively. The positivity obtained for conjunctival
swab in group B, in which both eyes were sampled, increased for 52.0%. The following median
parasite load (parasites/ml) was found for each sample: conjunctival swab 10 (range 1-5000),
oral swab 7 (range 2-100), lymph node aspirates 16, 500 (range 2-75, 000) and blood 7 (range
2-14). The similar positive PCR percentages obtained for lymph node aspirates and conjunc‐
tival swab, based on at least one conjunctival sample, reinforced the use of this non-invasive
alternative for the detection of Leishmania infected dogs. The study did not show significant
association between antibody titers and percentage of positive conjunctival swab PCR, but
seropositive and lymph node PCR positives dogs showed a high likelihood to be positive by
conjunctival PCR. No association was also found between clinical status and individual
molecular results, in especial between the presence of ocular lesions and positive conjunctival
PCR. Interestingly, the study demonstrated the presence of Leishmania DNA in oral swabs of
dogs without any evidence of oral lesions. Therefore oral swab PCR was not a sensitive
diagnostic method, the study emphasized that further studies should investigate the impor‐
tance of this finding for risk of Leishmania transmission by licking or bites.
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The work of Ferreira et al. (2012)[25] corroborated the conjunctival swab applicability for
canine visceral leishmaniasis diagnosis. In this study the kDNA PCR-hybridization and the
quantitative real-time PCR were used, respectively, for diagnosis and assessment of parasite
load in clinical samples of 80 naturally infected dogs. The dogs were divided in two groups:
without clinical manifestations (1) and presenting clinic signs associated with visceral leish‐
maniasis (2). All animals had positive ELISA and IFAT and/or parasitological positive test. The
negative control group included 10 health dogs that tested negative in the serological and
parasitological tests. The kDNA PCR-hybridization positive results rates for the clinical
samples in the Group 1 were as follow: right conjunctiva, 77.5% (31/40); left conjunctiva, 75.0%
(30/40); skin, 45.0% (18/40); bone marrow, 50.0% (20/40) and blood, 27.5% (11/40). By combining
the results of both conjunctivas the positivity was 87.5% (35/40). For the group 2 the PCR-
hybridization allowed the following results: right conjunctiva, 95% (38/40); left conjunctiva
87.5% (35/40); bone marrow, 77.5% (31/40) and blood 22.5% (9/40). A positivity of 95.0% (38/40)
was obtained considering the positive results of both conjunctivas. For qualitative molecular
diagnosis the conjunctival swab samples showed the best results for both dogs groups. The
quantitative real-time PCR was performed using primers addressed to a fragment of a single-
copy-number L. infantum DNA polymerase gene. Canine housekeeping β-actin gene was used
as endogenous control. The results were defined as the number of parasites per 104 canine
cells. For both groups the parasite burdens determinate by the quantitative real time PCR in
conjunctival swab and bone marrow were statistically equivalent, by the other side the parasite
load in the skin was higher than the other clinical samples. When compared between groups
the parasite load from conjunctival swab in group 2 was higher than in group 1. The same
relationship was found for bone marrow. However, no differences were observed in skin load
between groups. The high parasite burdens detected in skin from both symptomatic and
asymptomatic animals emphasized the role of infected dogs, especially the asymptomatic, as
reservoir. The article considered the conjunctival swab sampling procedure suitable form
molecular diagnosis of canine visceral leishmaniasis and suggested their widespread use.
An interesting study to evaluate the conjunctical swab diagnostic performance in different
stages of infection and also for the follow up of dogs undergoing antileishmanial treatment
was conducted by Di Muccio et al. (2012)[59]. To achieve the first objective 253 dogs from areas
of endemicity from central Italy were submitted to a cross-sectional survey. For the second
aim was performed a longitudinal study using 20 sick dogs under treatment. The molecular
assay was a nested PCR using primes addressed to the small-subunit rRNA gene. Among the
253 animals the rates of Leishmania infection were 21.73% for conjunctival swab PCR, 21.34%
for IFAT, 14.22% for popliteal lymph node cytological examination and 8.69% for buffy coat
PCR. Seventy two dogs were positive by at least one test and considered positives for canine
visceral leishmaniasis. Among these 72 dogs 76.38% were positive for conjunctival swab PCR,
75.0% for IFAT, 50.0% for lymph node cytological examination and 30.55% for buffy coat PCR.
The conjunctival swab PCR showed the best performance and presented a high concordance
in relation to IFAT (κ = 0.75). Test correlation with infection and clinical staging were analyzed
in 54 IFAT seropositive dogs. Seven dogs were classified as exposed (low IFAT titer plus
negative cytology and negative PCR), 38 as infected (low IFAT titer plus positive cytology and/
or positive PCR but without clinical signs) and 9 as sick (high IFAT titer plus positive cytology
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and with at least one clinical sign). The conjunctival swab PCR showed the best positivity in
the infected group (84.2%, 32/38 dogs) followed by lymph node cytological examination
(77.8%, 7/9 dogs) and buffy coat PCR (42.1%, 16/38). The positivity of conjunctival swab PCR
was also high in the symptomatic group (77.8%, 7/9 dogs), the lymph node cytological
examination detected 9/9 dogs (100%) and buffy coat PCR 33.3% (3/9 dogs). In the group
exposed, none of the three methods was able to detect infection. Eighteen dogs were negative
by IFAT and 16 of these dogs were positive by conjunctival swab PCR and 3 by buffy coat PCR.
In the longitudinal study using 20 sick dogs, all of them were positive by IFAT and conjunctival
swab PCR (100%) at the beginning of the study, whereas 17 tested positive in the lymph node
cytological examination (85%) and 9 in the buffy coat PCR (45%). After three months, the
therapy protocols promoted a total remission of clinical signs and decrease of antibody titers
with reduction in the positivity rates for conjunctival PCR (30%), lymph node cytological
examination (10%) and buffy coat PCR (5%). After six months of treatment was verified an
increase in the positivity for conjunctival swab PCR (88.89%) and buffy coat PCR (44.44%) and
a less marked increase in lymph node cytological examination positivity (22.22%), without
reappearance of clinical signs or increase in serological titers. These results demonstrated that
conjunctival swab PCR was sensitive for the early detection of relapses and suitable to monitor
the evolution of infection after therapy.
Ferreira et al. (2013) [60] compared conjunctival and nasal swabs with other clinical samples
in 62 naturally infected dogs (58 of them symptomatic). L. donovani complex specific primers
addressed to kDNA minicircle conserved region were used. The following frequencies of
positive results were obtained: nasal swab, 87% (54/62); conjunctival swab, 76% (47/62); skin
biopsy, 81% (50/62); bone marrow biopsy, 90% (56/62). Positivity obtained using nasal swabs
was statistically equivalent to those obtained with the other samples, but in this study the
conjunctival swab showed a lower frequency of positivity than that calculated for bone marrow
samples, probably due to the PCR protocol used. The parasite load was estimated by qPCR,
using primers addressed to the parasite DNA polimerase gene and the canine β-actin gene as
a housekeeping gene. The parasite load from conjunctival and nasal samples were equivalent,
but lower than verified in bone marrow and skin samples. Oral and ear swabs were also
evaluated in a smaller group of 28 animals. Positive results were: oral swab, 79% (22/28) and
ear swab, 43% (12/28). The results of this study indicated that conjunctival, nasal and oral swabs
were effective in detecting Leishmania in naturally infected dogs. The authors suggested that
a combination of these samples would be useful in large-scale screening of dogs.
3. Conclusions
In the Mediterranean, Southern Europe and South and Central America, with approximately
500, 000 new human visceral leishmaniasis cases reported annually and millions of dogs
infected, being dogs considered to be the major reservoirs for the disease, the accurate
diagnosis in these animals is extremely important. Diagnosis of canine visceral leishmaniasis
is performed mainly by direct parasitological methods that can yield false-negative results,
either because of the very low number of Leishmania spp. organisms in clinical samples (bone
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marrow and lymph nodes) or because morphological identification is difficult. In addition,
these methods are invasive. Another problem mentioned is that serology is not sufficient as a
criterion for eliminating infected dogs. Conventional serological techniques are limited by
cross-reactivity with other parasitic diseases, because several technical procedures have not
been standardised and due the low sensitivity of the available serological methods in the initial
stages of infections.
In dogs PCR-based assay is currently the more sensitive and specific technique for detection
of Leishmania and it allows using different clinical samples. The conjunctival swab is a non-
invasive sample recently reported and up to moment few studies have been performed using
this approach. Nevertheless, its high sensitivity and applicability for molecular diagnosis of
canine visceral leishmaniasis have been confirmed, independently, by different research
groups.
The studies demonstrated that the method allows the identification of infected dogs before the
seroconversion and that conjunctival swab sensitivity for molecular diagnosis was superior or
equivalent to obtained by invasive samples of either symptomatic or asymptomatic animals.
The conjunctival swab was also proved useful to monitor the dogs during drug therapy. The
molecular diagnosis using non-invasive samples such conjunctival swab is of great relevance
in epidemiological studies when large numbers of dogs are sampled and also for clinical or
experimental purposes, that implies repeated samplings. The standardization of this sampling
procedure can help to become viable and widespread the molecular diagnosis of canine
visceral leishmaniasis. The DNA extraction protocol and the sensitivity of PCR assay used are
important variables to be considered in order to obtain the best results. Field studies in wide
heterogeneous populations including seronegative and seropositive animals and works that
follow up PCR positive seronegative dogs are still lacking and are very important for the
method validation.
Molecular tests are yet comparatively expensive in relation to other diagnostic techniques
available and require technological expertise, but considering the data presented above, a
sensitive, specific and practical test could provide very cost-effective alternatives to currently
available diagnostic tests, especially when used in mass-screening surveys.
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